Journals / Turkish Journal of Gastroenterology / 2022 / Cilt: 33 - Sayı: 4

Effects of Probiotic Bacteria on Central Neuronal Activation in Experimental Colitis

Pages
304–311
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Probiotics diversely modulate limbic response and hypothalamic axis activity in addition to protective effects inflammation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Brain–gut axis dysregulation is observed in inflammatory bowel disease.
📊
Key Findings & Data:Methods: In this study, 28 Sprague–Dawley rats were divided into 4 groups: colitis-probiotic group, non-colitis-fed-control group receiv- ing probiotic Lactobacillus delbrueckii subsp.
💡
Conclusion & Impact:Probiotics diversely modulate limbic response and hypothalamic axis activity in addition to protective effects inflammation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: Brain–gut axis dysregulation is observed in inflammatory bowel disease. However, the effect of altered gut flora on neuro- immunomodulation and its role in the pathogenesis of inflammatory bowel disease are unknown. The aims of this study are to determine (i) whether colitis modifies the expression of c-fos, a marker of general neuronal activation in the brain and (ii) whether this activation could be modulated by probiotic bacteria. Methods: In this study, 28 Sprague–Dawley rats were divided into 4 groups: colitis-probiotic group, non-colitis-fed-control group receiv- ing probiotic Lactobacillus delbrueckii subsp. Bulgaricus B3 strain for 7 days, colitis group, and sham group receiving only sodium chlo- ride. Colitis was induced by intracolonic administration of trinitrobenzene sulfonic acid–ethanol. The expression of c-fos was detected by immunohistochemistry in the brain tissue. Cytokines and inflammatory mediators were analyzed in the plasma. Histological scores and oxidative status were analyzed in the colon samples. Results: The inflammatory response was accompanied by increased levels of cytokines, lipid peroxidation activities, c-fos expression in the medial nucleus of the amygdala, and decreased levels of antioxidant enzymes in the colitis (P < .001). Probiotic treatment reversed those effects. Also, histopathologic scores were significantly lower in the probiotic-treated groups compared to the colitis group (P = .035). In contrast, the expression of c-fos was significantly increased in the paraventricular nucleus of hypothalamus in the probiotic- treated rats (P < .001). Conclusion: Colitis and intestinal inflammation are associated with the activation of neurons in the limbic system creating stress-like effects in the brain. Probiotics diversely modulate limbic response and hypothalamic axis activity in addition to protective effects inflammation.

🔖

Cite This Article

ŞENGÜL, N., TÖRE, F., IŞIK, S., ASLIM, B., UÇAR, G., FIRAT, T., ÇİFTÇİ, S. Y., KÜKNER, A. (2022). Effects of Probiotic Bacteria on Central Neuronal Activation in Experimental Colitis. Turkish Journal of Gastroenterology, Cilt: 33 - Sayı: 4, 304–311. https://ajindex.com/articles/408839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota- gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol. 2014
  2. 592(14):2989-2997. [CrossRef] 2.Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015
  3. 28(2):203-209. 3. Wang Y, Kasper LH. The role of microbiome in central nervous sys- tem disorders. Brain Behav Immun. 2014
  4. [CrossRef] 4. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science. 2012
  5. 336(6086):1262-1267. [CrossRef] 5. Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012
  6. 18(5):968-984. [CrossRef] 6. Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia- Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010
  7. 11(3):134-147. [CrossRef] 7. Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of probiotics on gut microbiota in patients with inflammatory bowel disease: a double-blind, placebo-controlled clinical trial. Korean J Gastroenterol. 2015
  8. 65(4):215-221. [CrossRef] 8. Yılmaz İ, Dolar ME, Özpınar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019
  9. 30(3):242-253. [CrossRef] 9. Wilkins T, Sequoia J. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Physician. 2017
  10. 96(3):170-178. 10. Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta-analysis and systematic review. J Cell Physiol. 2018
  11. 233(3):2091-2103. [CrossRef] 11. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005
  12. 54(10):1481-1491. [CrossRef] 12. Häuser W, Janke KH, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2011
  13. 17(2):621-632. [CrossRef] 13. Ait-Belgnaoui A, Eutamene H, Houdeau E, Bueno L, Fioramonti J, Theodorou V. Lactobacillus farciminis treatment attenuates stress- induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats. Neurogastroenterol Motil. 2009
  14. 21(5):567-73, e18. [CrossRef] 14. Kilinc E